Sunday, April 4, 2021

Questions about AstraZeneca jab linger

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against COVID-19 are more frequent than in the general population, and what causes them if they are, have continued to undermine confidence in the beleaguered vaccine.